We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GMAB icon
326
Genmab
GMAB
$17.6B
$5.62M 0.05%
153,563
+7,133
+5% +$258K
LNG icon
327
Cheniere Energy
LNG
$54.1B
$5.58M 0.05%
120,565
-1,099
-0.9% -$55.7K
DELL icon
328
Dell
DELL
$262B
$5.54M 0.05%
161,622
-14,644
-8% -$457K
TGT icon
329
Target
TGT
$65.6B
$5.51M 0.05%
35,018
-1,748
-5% -$240K
DPZ icon
330
Domino's
DPZ
$11.7B
$5.51M 0.05%
12,960
-118
-0.9% -$47K
AMP icon
331
Ameriprise Financial
AMP
$48.1B
$5.46M 0.05%
35,418
-37,907
-52% -$5.84M
KGC icon
332
Kinross Gold
KGC
$28.2B
$5.44M 0.05%
453,153
-38,990
-8% -$337K
RY icon
333
Royal Bank of Canada
RY
$292B
$5.43M 0.05%
77,588
+9,076
+13% +$652K
ES icon
334
Eversource Energy
ES
$27.8B
$5.42M 0.05%
64,936
-26,653
-29% -$2.28M
PVH icon
335
PVH
PVH
$4.01B
$5.4M 0.05%
90,497
-9,632
-10% -$530K
ROP icon
336
Roper Technologies
ROP
$38.5B
$5.38M 0.05%
13,623
-551
-4% -$229K
CLX icon
337
Clorox
CLX
$11.7B
$5.38M 0.05%
25,604
+14,320
+127% +$3.19M
OTIS icon
338
Otis Worldwide
OTIS
$27.3B
$5.37M 0.05%
86,002
+56,008
+187% +$3.43M
ORA icon
339
Ormat Technologies
ORA
$5.94B
$5.32M 0.05%
89,934
+1,882
+2% +$114K
SNDX icon
340
Syndax Pharmaceuticals
SNDX
$1.73B
$5.29M 0.05%
358,372
+10,914
+3% +$166K
ZION icon
341
Zions Bancorporation
ZION
$10.1B
$5.28M 0.05%
180,645
-74,558
-29% -$2.4M
NVAX icon
342
Novavax
NVAX
$1.22B
$5.26M 0.05%
+48,575
New +$5.92M
NKTR icon
343
Nektar Therapeutics
NKTR
$2.41B
$5.24M 0.05%
21,062
– –
ED icon
344
Consolidated Edison
ED
$40.4B
$5.04M 0.05%
64,767
+657
+1% +$48.5K
PNC icon
345
PNC Financial Services
PNC
$99.2B
$5.02M 0.05%
45,707
+9,668
+27% +$1.04M
ZTS icon
346
Zoetis
ZTS
$31.9B
$4.99M 0.05%
30,192
-2,053
-6% -$315K
FDX icon
347
FedEx
FDX
$73B
$4.93M 0.05%
19,586
-2,354
-11% -$471K
MFC icon
348
Manulife Financial
MFC
$74B
$4.92M 0.05%
355,119
+15,298
+5% +$219K
MU icon
349
Micron Technology
MU
$988B
$4.91M 0.05%
104,639
+14,732
+16% +$713K
BKR icon
350
Baker Hughes
BKR
$59.5B
$4.84M 0.05%
364,360
+31,634
+10% +$484K
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.